Prognosis of metastatic castration-resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells

被引：0
|
作者：
Nagaya, N. [1 ]
Nagata, M. [1 ]
Ashizawa, T. [1 ]
Lu, Y. [1 ]
Fujita, K. [1 ]
Horie, S. [1 ]
机构：
[1] Juntendo Univ, Urol, Grad Sch Med, Bunkyo ku, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.401
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
275P
引用
收藏
页码：S1579 / S1580
页数：2
相关论文
共 50 条
  • [31] Metabolic Reprogramming of Castration-Resistant Prostate Cancer Cells as a Response to Chemotherapy
    Petrella, Greta
    Corsi, Francesca
    Ciufolini, Giorgia
    Germini, Sveva
    Capradossi, Francesco
    Pelliccia, Andrea
    Torino, Francesco
    Ghibelli, Lina
    Cicero, Daniel Oscar
    METABOLITES, 2023, 13 (01)
  • [32] The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer
    Friedlander, Terence W.
    Fong, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) : 1104 - +
  • [33] Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
    Maillet, Denis
    Allioli, Nathalie
    Peron, Julien
    Plesa, Adriana
    Decaussin-Petrucci, Myriam
    Tartas, Sophie
    Sajous, Christophe
    Ruffion, Alain
    Crouzet, Sebastien
    Freyer, Gilles
    Vlaeminck-Guillem, Virginie
    CANCERS, 2021, 13 (23)
  • [34] The Experience with Cytotoxic Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
    Eisenberger, Mario A.
    Antonarakis, Emmanuel S.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 573 - +
  • [35] Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?
    Has Simsek, Duygu
    Kuyumcu, Serkan
    Karadogan, Seyfullah
    Oflas, Melis
    Isik, Emine Goknur
    Ozkan, Zeynep Gozde
    Paksoy, Nail
    Ekmekcioglu, Ozgul
    Ekenel, Meltem
    Sanli, Yasemin
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (06) : 680 - 690
  • [36] Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?
    Duygu Has Simsek
    Serkan Kuyumcu
    Seyfullah Karadogan
    Melis Oflas
    Emine Goknur Isik
    Zeynep Gozde Ozkan
    Nail Paksoy
    Ozgul Ekmekcioglu
    Meltem Ekenel
    Yasemin Sanli
    Annals of Nuclear Medicine, 2021, 35 : 680 - 690
  • [37] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
  • [38] Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
    Leon-Mateos, Luis
    Abalo, Alicia
    Casas, Helena
    Anido, Urbano
    Rapado-Gonzalez, Oscar
    Vieito, Maria
    Suarez-Cunqueiro, Mercedes
    Gomez-Tato, Antonio
    Abal, Miguel
    Lopez-Lopez, Rafael
    Muinelo-Romay, Laura
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
  • [39] Gene Expression Alterations during Development of Castration-Resistant Prostate Cancer Are Detected in Circulating Tumor Cells
    Josefsson, Andreas
    Larsson, Karin
    Freyhult, Eva
    Damber, Jan-Erik
    Welen, Karin
    CANCERS, 2020, 12 (01)
  • [40] Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer
    McDaniel, Andrew S.
    Ferraldeschi, Roberta
    Krupa, Rachel
    Landers, Mark
    Graf, Ryon
    Louw, Jessica
    Jendrisak, Adam
    Bales, Natalee
    Marrinucci, Dena
    Zafeiriou, Zafeiris
    Flohr, Penelope
    Sideris, Spyridon
    Crespo, Mateus
    Figueiredo, Ines
    Mateo, Joaquin
    de Bono, Johann S.
    Dittamore, Ryan
    Tomlins, Scott A.
    Attard, Gerhardt
    BJU INTERNATIONAL, 2017, 120 (5B) : E30 - E44
12345